|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 21-01-19 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 20-12-22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 2019-12-31 |
Patty Meehan
ADM | Chief Administrative Officer | - | 2001-12-31 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kyle C. Kerbawy
CHM | Chairman | 79 | 2015-07-31 |
Sally L. Maher
BRD | Director/Board Member | - | 2019-04-30 |
| Director/Board Member | 71 | 2019-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 340M | |
| +1.11% | +5.04% | -15.25% | +4.66% | 190B | |
| +0.07% | +5.73% | -1.26% | +9.33% | 116B | |
| -5.95% | -0.70% | +8.94% | +67.89% | 63.71B | |
| -0.91% | +0.33% | +34.28% | +58.74% | 55.13B | |
| +1.16% | +7.41% | -5.98% | -35.15% | 49.41B | |
| +1.44% | +10.11% | +13.53% | -21.37% | 33.79B | |
| +3.20% | -2.81% | - | - | 30.74B | |
| +0.22% | +0.41% | +46.92% | -11.86% | 24.73B | |
| +0.89% | +11.86% | -5.01% | +19.22% | 23.85B | |
| Average | -0.09% | +2.73% | +9.52% | +11.43% | 58.76B | |
| Weighted average by Cap. | -0.07% | +4.03% | +1.12% | +13.00% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 89.22M 77.3M 72.43M 66.06M 124M 8.51B 126M 852M 333M 4.26B 335M 328M 14.21B | 101M 87.33M 81.82M 74.63M 140M 9.61B 142M 962M 376M 4.81B 378M 370M 16.05B |
| Net income | -3.13M -2.71M -2.54M -2.32M -4.36M -299M -4.43M -29.9M -11.69M -150M -11.76M -11.5M -499M | 1.45M 1.26M 1.18M 1.07M 2.02M 138M 2.05M 13.83M 5.41M 69.19M 5.44M 5.32M 231M |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
